21st.BIO A/S
CVR 41554908 · Public limited company (A/S) · Active · Low risk
21st.BIO A/S is a Public limited company (A/S), founded on , based in Søborg. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 5 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 202.5m and a net result of DKK -127.8m. CEO: Thomas Günther Schmidt, Thomas Troelsgaard Kabel, Mikael Bechsgaard, Jose Arnau Martinez, Henrik Marcus Geertz-Hansen.
Bankruptcy risk for 21st.BIO A/S
0.6 × the average (1.41%) · higher risk than 70% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 41554908
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (6 years)
- Address
- Sydmarken 42
2860 Søborg - Municipality
- Gladsaxe
- Industry
- Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder - Share capital
- DKK 16.7m
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 5 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 59.4% |
| Current ratio | 339% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 8 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 7 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -15.5m | DKK -17.2m | DKK -9.8m |
| Net profit | DKK -127.8m | DKK -41.7m | DKK -42.3m |
| Equity | DKK 202.5m | DKK 330.3m | DKK 294.8m |
| Total assets | DKK 341.0m | DKK 440.9m | DKK 419.2m |
| Cash | DKK 27.9m | DKK 89.9m | – |
| Short-term debt | DKK 32.7m | DKK 13.4m | – |
| Avg. employees | 37 | 30 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 177 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 134 | ||
| 1 Jan 2022 – 31 Dec 2022 | 143 | ||
| 1 Aug 2020 – 31 Dec 2021 | 147 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Thomas Günther Schmidt | Current | |
| CEO | Thomas Troelsgaard Kabel | Current | |
| CEO | Mikael Bechsgaard | Current | |
| CEO | Jose Arnau Martinez | Current | |
| CEO | Henrik Marcus Geertz-Hansen | Current | |
| CEO | Per Falholt | ||
| CEO | Thorvald Uhrskov Ullum | ||
| Board | Thomas Günther Schmidt | Current | |
| Board | Claus Crone Fuglsang | Current | |
| Board | Thomas Grotkjær | Current | |
| Board | Thomas Dal Stenfeldt Batchelor | Current | |
| Board | Anders Bendsen Spohr | Current | |
| Board | Steen Riisgaard | ||
| Board | Per Falholt | ||
| Board | Niels Jørgen Kornerup | ||
| Board | Anders Bendsen Spohr | ||
| Board | Søren Møller | ||
| Board | Amy Louise Byrick | ||
| Owner (33%) | NOVOZYMES A/S | Current | |
| Owner (5%) | Momentum Techinvest ApS | Current | |
| Owner (33%) | Novo Holdings A/S | Current | |
| Owner (33%) | Steen Riisgaard | ||
| Owner (33%) | LILLE FREDERIKSLUND INVEST ApS | ||
| Owner (33%) | Momentum Techinvest ApS | ||
| Owner (50%) | LILLE FREDERIKSLUND INVEST ApS | ||
| Owner (50%) | Momentum Techinvest ApS | ||
| Owner (100%) | Momentum Techinvest ApS | ||
| Owner (67%) | Novo Holdings A/S | ||
| Owner (25%) | Momentum Techinvest ApS | ||
| Owner (33%) | Novo Holdings A/S | ||
| Owner (50%) | Novo Holdings A/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | Steen Riisgaard | Current | |
| Founder | LILLE FREDERIKSLUND INVEST ApS | Current | |
| Founder | Momentum Techinvest ApS | Current |
The CEOs' other companies
Thomas Günther Schmidt – 3 other companies
- DHI A/S Active
- KOMPLEMENTARSELSKABET MCKINSEY ApS Active
- LACTOBIO A/S Fusioneret
Thomas Troelsgaard Kabel – 1 other companies
- Glycom Manufacturing A/S Active
Mikael Bechsgaard – 3 other companies, of which 1 bankrupt
- Anpartsselskabet af 29. marts 2017 Bankrupt 30 Mar 2017
- Agrobiomics ApS Active
- Pretty Bird Living ApS Opløst
Jose Arnau Martinez – 4 other companies
- CRAKSA Holding ApS Active
- Fructibio ApS Active
- Fructibio Holding ApS Active
- Way Ahead ApS Active
Per Falholt – 28 other companies, of which 2 bankrupt
- CYTOVAC A/S Bankrupt 18 Mar 2025
- K/S VICTORIA STREET Bankrupt 25 Oct 2018
- ACTUO A/S Active
- ARTS BIOLOGICS A/S Opløst
- ApS KBIL 9 NR. 702 Compulsorily dissolved
- Bactolife A/S Active
- CO-RO A/S Active
- CO-RO HOLDING A/S Fusioneret
- CURASIGHT A/S Active
- DANFOSS A/S Active
- EUROPEAN PROTEIN A/S Active
- FERMENTATIONEXPERTS A/S Active
- FermBiotics ApS Active
- FermBiotics Holding ApS Fusioneret
- LACTOBIO A/S Fusioneret
- LIFE A/S Active
- LILLE FREDERIKSLUND INVEST ApS Active
- Lille Frederikslund Tech Invest ApS Active
- NOVOZYMES A/S Active
- NOVOZYMES BIOPOLYMER A/S Fusioneret
- PER FALHOLT GLOBAL R&D ADVISORY SERVICES A/S Active
- People Ventures General Partner I ApS Active
- People Ventures Management ApS Active
- ProviPartners ApS Active
- Synamics Therapeutics ApS Active
- Vitibiotech ApS Active
- VÅDFODEREKSPERTEN A/S Fusioneret
- XcelCyte A/S Opløst
Thorvald Uhrskov Ullum – 1 other companies
- EJ SIKKE LEJ A/S Opløst
Address history (2 moves)
| Sydmarken 42, 2860 Søborg | |
| Teknikerbyen 5, 2., 2830 Virum | |
| Øresundshøj 15, 2920 Charlottenlund |
Former names
| 21st.BIO A/S | – now |
| Copenhagen Bio Partners A/S | – |
Other companies at the same address
- NCC ÈNFAMILIEHUSE A/S Fusioneret
- NORDISK TOBAKS KOMPAGNI A/S Fusioneret
- SKANDINAVISK GROUP A/S Opløst
- SKANDINAVISK HOLDING II A/S Fusioneret
- ST SALES A/S Fusioneret
- STANWELL A/S Opløst
- STG HOLME REAL ESTATE ApS Opløst
Similar companies in Gladsaxe
- Human House A/S Søborg
- Bluebox Instruments ApS Bagsværd
- Velocity Engineering ApS Søborg
- Pharma Operations Consulting & Development ApS Bagsværd
- Æbler og Pærer ApS Bagsværd
- RadPoly ApS Søborg
- Visibuilt ApS Søborg
- Trygt Vand ApS Bagsværd
- Vortex Pharma Solution ApS Bagsværd
- Core Renewables ApS Søborg
- Trap Rose & Ekblad, Rådgivende Ingeniører og Biologer ApS Søborg
- YOPCON ApS Bagsværd
Questions and answers about 21st.BIO A/S
Has 21st.BIO A/S gone bankrupt?
No, 21st.BIO A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of 21st.BIO A/S?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of 21st.BIO A/S?
Thomas Günther Schmidt, Thomas Troelsgaard Kabel, Mikael Bechsgaard, Jose Arnau Martinez, Henrik Marcus Geertz-Hansen are the CEOs of 21st.BIO A/S.
Who is the auditor of 21st.BIO A/S?
21st.BIO A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was 21st.BIO A/S founded?
21st.BIO A/S was founded on 1 August 2020.
What is the equity of 21st.BIO A/S?
Equity was DKK 202.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.